Guosen H&S Investments
VC Fund
Futian, China
Guosen H&S Investments is a VC fund in Futian focused on Biotechnology and Manufacturing. Guoxin Hongsheng Venture Capital Co., Ltd. ("Guoxin Hongsheng") was established on August 8, 2008 with a registered capital of 4.05 billion yuan. It is a wholly-owned private equity investment fund of Guosen Securities Co., Ltd. ("Guoxin Securities"). Manage subsidiaries. As an important platform for Guosen Securities'comprehensive financial services, Guoxin Hongsheng is engaged in equity investment, equity investment fund management, equity investment advisory, etc. through the establishment and management of investment funds, and is committed to creating value for investors and enterprises. win. As of December 31, 2017, Guoxin Hongsheng wholly owned or controlled 11 fund management subsidiaries, with 10 investment funds and an asset management scale of over RMB 10 billion.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Guosen H&S Investments invests in
Stages Guosen H&S Investments invests in
Countries Guosen H&S Investments invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series A
- $1.4M–$14M
- Series B
- $2.8M–$14M
- Series C
- $4.3M–$89M
Investment Focus
Industry
- Biotechnology 4 (22%)
- Manufacturing 4 (22%)
- Health Care 3 (17%)
- Semiconductor 3 (17%)
- Internet 2 (11%)
Stage
- Series A 6 (33%)
- Series B 3 (17%)
- Series C 3 (17%)
- Venture - Series Unknown 2 (11%)
- Seed 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chai Kechao
Investment Director
|
Investment Director | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Delova Biotech
|
Delova Biotech specializes in the field of pain treatment. It uses the company's rich R&D experience and special preparation technology platform to improve existing drugs and conduct research and development of improved new analgesics in China and the United States. | $88.6M / Series C / Jul 22, 2026 | |
Greenon Biotech
|
Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on. | $14.2M / Series B / Dec 22, 2025 | |
Shangji Semiconductor
|
Shangji Semiconductor manufactures semiconductor equipment for microelectromechanical and integrated circuit industries. | $42.4M / Venture - Series Unknown / Dec 04, 2025 | |
Juyue Testing
|
Juyue Testing is an integrated circuit service provider, primarily offering professional and efficient chip testing and analysis services. | $14M / Series A / Nov 07, 2025 | |
Huapai Biotechnology
|
Huapai Bio is a group-based animal health organization that specializes in the research and development, manufacturing, sales, and technical support of animal health products . | Aug 14, 2024 | |
|
Huapai Biotechnology
|
Huapai Bio is a group-based animal health organization that specializes in the research and development, manufacturing, sales, and technical support of animal health products . | Series A / Aug 14, 2024 | |
Global Technology
|
Global Technology is a leading supplier of automotive intelligent driving systems.The company is led by R&D, and has a complete vehicle system matching capability. It is a high-tech enterprise integrating design, R&D, production, sales and service. The company's main business is EPB, pneumatic / hydraulic ABS / ESP, ADASand other automotive electronic active safety products. With senior technical experts in automotive pneumatics, hydraulic brakes and electronic control, the company has OEM market model matching analysis and forward development capabilities. | $58M / Series C / Apr 23, 2023 | |
Silk Road Interconnection
|
Silk Road Internet mainly provides Amazon's agency operation services, including production planning, store operations, marketing promotion, warehousing and logistics management, etc., for the US market. | Seed / Mar 11, 2022 | |
Yiwei Semiconductor
|
Yiwei Semiconductor is an SoC chip design company for robot motion control and synchronous positioning and navigation purposes. | $15.7M / Venture - Series Unknown / Dec 13, 2021 | |
Sunmnet
|
Sunmnet specializes in providing smart education technology and solutions. It utilizes big data, artificial intelligence, facial recognition, and IoT that enables clients to develop efficient education systems and infrastructure. | Series A / Apr 08, 2020 | |
| See all 18 investments → | |||
Co-Investors
Guangzhou Industrial Investment Group
2 deals together
Jinmu capital
2 deals together
Benyu Investment
1 deal together
CASH Capital
1 deal together
CICC
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Guosen H&S Investments invest in?
Guosen H&S Investments invests primarily in Biotechnology, Manufacturing and Health Care startups, most often at Series A and Series B stage. Most of the 18 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Guosen H&S Investments's check size?
Guosen H&S Investments typically joins rounds of $1.4M–$14M at Series A, $2.8M–$14M at Series B and $4.3M–$89M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Guosen H&S Investments participates in.
How do I contact Guosen H&S Investments?
Public channels for Guosen H&S Investments include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Guosen H&S Investments?
The team at Guosen H&S Investments includes Chai Kechao (Investment Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
